h ypoxic ischemic brain injury affects 53-76% of children successfully resuscitated from cardiac arrest (CA) (1) . Brain tissue hypoxia, cerebral hypoperfusion, and impaired autoregulation in the early post-CA syndrome have potential implications for secondary brain injury in patients successfully resuscitated from CA. The International Liaison Committee on Resuscitation emphasized in a recent statement that good neurological outcome is contingent upon optimal post-CA care and identified important knowledge gaps in (i) optimal oxygen delivery during the initial stages of reperfusion and (ii) optimal cerebral monitoring after CA (2) . Early optimization of cerebral oxygen delivery to meet metabolic demands may reduce the neurological damage associated with post-CA brain injury.
After experimental pediatric asphyxial CA, cortical regions have decreased perfusion, while thalamic regions are hyperemic (3) . Cortical hypoperfusion observed in our model may be associated with cortical hypoxia. Serial and regional partial pressure of brain tissue oxygen (PbO 2 ) after experimental asphyxial CA has not been characterized. Multiple studies have demonstrated that after traumatic brain injury, direct monitoring of PbO 2 is safe, and some studies have suggested that targeting specific thresholds for PbO 2 has been associated with improved outcomes compared with historical controls (4) (5) (6) (7) (8) . Although brain tissue monitoring was included in the treatment guidelines for adult victims of traumatic brain injury in 2007, PbO 2 monitoring after pediatric CA is not used routinely.
Based on our previous studies of postresuscitation cerebral perfusion, we hypothesized that important differences in regional PbO 2 would be observed during early post-CA syndrome after experimental asphyxial CA and that clinically relevant interventions such as hyperoxia and blood pressure augmentation would influence PbO 2 . Table 1 presents physiological data for the groups of rats that underwent CA. Mean arterial pressure (MAP) increased at 5-10 min postresuscitation, then decreased, and was lower than baseline after 30 min postresuscitation. The baseline MAP was lower in the 12 min asphyxial CA groups that underwent thalamic PbO 2 measurements vs. 9 min asphyxial CA that underwent cortical or thalamic PbO 2 measurements (55 ± 2 vs. 67 ± 2 and 72 ± 4 mm Hg, respectively; P < 0.05). PaCO 2 was maintained in the normal range at all time points except for an increase to 46 ± 1.6 mm Hg only at 60 min postresuscitation in the 9 min thalamic group. Hemoglobin decreased vs. baseline at 30, 60, and 120 min after 9 and 12 min CA, with no difference between groups at each time point.
RESULTS
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Baseline PbO 2 was similar for cortical and thalamic areas. After the onset of asphyxia, PbO 2 decreased to less than 5 mm Hg within 60 s in both regions and in all rats. After cardiopulmonary resuscitation, we observed a rapid rise in PbO 2 in the thalamus and a more gradual rise in PbO 2 in the cortex. Figure 1a illustrates cortical PbO 2 after resuscitation from 9 and 12 min asphyxial CA. After 9 min asphyxial CA, mean cortical PbO 2 was similar to baseline at 5, 10, and 15 min (64 ± 22, 39 ± 8, and 33 ± 6 mm Hg at 5, 10, and 15 min, respectively) and then lower than baseline from 30 min (19 ± 4 mm Hg) to 120 min (25 ± 5 mm Hg) postresuscitation. After 12 min asphyxial CA, cortical PbO 2 was similar to baseline at 5-15 min (43 ± 18, 25 ± 7, and 25 ± 6 mm Hg) and then lower than baseline from 30 min (15 ± 4 mm Hg) to 120 min (9 ± 2 mm Hg) postresuscitation (Figure 1a) . Cortical PbO 2 was lower in rats subjected to 12 min asphyxial CA vs. 9 min asphyxial CA at 120 min postresuscitation (P < 0.05).
Figure 1b illustrates thalamic PbO 2 after resuscitation from 9 and 12 min asphyxial CA. After both 9 and 12 min asphyxial CA, thalamic PbO 2 was markedly increased vs. baseline at 5 min (281 ± 25 vs. 66 ± 16.3, and 256 ± 45 vs. 63 ± 6 mm Hg; P < 0.05 after 9 and 12 min asphyxia, respectively) and remained elevated at 10 min after resuscitation (151 ± 23 and 217 ± 50 mm Hg; P < 0.05 vs. baseline after 9 and 12 min asphyxia, respectively). After the initial increase, thalamic PbO 2 decreased toward baseline for the duration of monitoring and remained well above 20 mm Hg.
Post-CA Response of PbO 2 to Supplemental Oxygen
The response to supplemental oxygen was evaluated at 120 min after resuscitation from 9 or 12 min CA. At 120 min after resuscitation, the rats receive a fraction of inspired oxygen (FiO 2 ) = 0.5 in our model. At that time point, we decreased the FiO 2 to 0.21 and gradually increased the Thalamic PbO 2 gradually increased with increases in supplemental oxygen after both 9 and 12 min of asphyxia (Figure 2 ).
Post-CA Response of PbO 2 to Epinephrine Infusion
To determine whether low cortical PbO 2 levels after 12 min asphyxial CA were related to low MAP, we administered 
DISCUSSION
To our knowledge, this is the first study reporting direct measurements of PbO 2 in a model of pediatric asphyxial CA. Our data suggest important region-and insult duration-dependent alterations in PbO 2 after CA. Cortical PbO 2 was reduced in the first 2 h after resuscitation, especially after longer insults, reaching thresholds consistent with cerebral ischemia (9) . In distinct contrast, thalamic PbO 2 was markedly increased initially after CA and then returned to baseline. PbO 2 response to supplemental oxygen was also insult duration and region dependent. PbO 2 reflects the local oxygen concentration in brain tissue and serves as a marker of the balance between regional oxygen supply and consumption. It is influenced by cerebral blood flow (CBF), MAP, PaO 2 , hemoglobin concentration, and factors affecting diffusion of oxygen in brain (10) . In clinical studies, PbO 2 values less than 10 mm Hg are associated with higher risk for ischemic brain injury (11, 12) and with unfavorable outcome after traumatic brain injury (8) . Similar threshold values have not been reported in either experimental or clinical CA.
Post-CA cortical hypoxia in this study reached levels that are below the accepted PbO 2 ischemic thresholds of 20 (5) or even 10 mm Hg in humans (8, 11) . Human data demonstrated Black circles represent 9 min CA group and white circles represent 12-min CA group. n = 6 per group for thalamic PbO 2 measurements and n = 12 per group for cortical PbO 2 measurements. *P < 0.05 vs. baseline for 9 min insult. **P < 0.05 vs. baseline for 12 min insult. FiO 2 , fraction of inspired oxygen. Articles Manole et al.
ongoing ischemia and anaerobic metabolism in the cortex during the first 10 h and up to 40 h after CA (13, 14) . Similar to our study, in an experimental model of global cerebral ischemia produced by neck tourniquet in adult primates, PbO 2 was region dependent with cortical hypoxia starting at 1 h postischemia (15) . Conversely, upon resuscitation from neonatal hypoxia with brief (1 min) CA, Linner et al. (16) observed initial cortical hyperoxia followed by return to baseline levels in newborn piglets. This is consistent with the hypothesis that PbO 2 changes are insult-duration dependent, with shorter durations of CA producing less hypoxia, similar to our previously described insult-duration dependency of CBF post-CA (3). Age-related differences or species differences could also be involved. If this observation translates to children resuscitated from out-of-hospital CA, where the duration of no-flow is most often unknown, PbO 2 could have potential utility in insult-duration stratification and prognostication. Our data suggest that PbO 2 parallels CBF in our model. Post-CA cortical hypoxia mirrors the cortical hypoperfusion we previously observed, whereas thalamic hyperoxia parallels thalamic hyperemia (3). Isoflurane, shown to preferentially increase subcortical CBF (17) (18) (19) (20) , increased thalamic PbO 2 in our sham rats while having no effect on cortical PbO 2 (pilot data, not shown). The association between PbO 2 and CBF was also reported in noninjured rats (21) and models of global ischemia (22) . These observations suggest that continuous PbO 2 monitoring may be used as a surrogate marker for cerebral perfusion early after CA.
Supplemental oxygen increased thalamic and cortical PbO 2 , with a more robust effect after 9 vs. 12 min CA. It was previously reported that the response of PbO 2 to hyperoxia is diminished in pathological compared with normal tissue (23) (24) (25) , and increased supplemental oxygen does not correspond to an improvement in brain oxygen delivery in areas with severely reduced CBF (26) . We previously reported that CBF is decreased in cortex, more pronounced after prolonged insults, and increased in thalamus after CA in our model (3). Our findings are in accordance with the hypothesis that raising FiO 2 in the injured brain yields an increase in PbO 2 but is highly dependent on adequate CBF. These observations suggest that interventions targeted to increase PbO 2 after long durations of CA should primarily focus on increasing CBF. Further studies of strategies to increase cortical PbO 2 via blood flow promoting vasodilatatory agents are warranted. Possible CBF promoting strategies include endothelin receptor antagonists (27) , nitrite (28) , or inhibition of 20-HETE (29), among other therapies. In our study, conditions of mild arterial hypoxemia, on the contrary, resulted in lower PbO 2 in shams and post-CA, suggesting that arterial hypoxemia should be avoided post-CA.
Increasing MAP using epinephrine infusion after long insults did not significantly increase cortical PbO 2 , although it increased thalamic PbO 2 at high doses only. This suggests that nonspecific interventions such as MAP augmentation may not be sufficient to increase PbO 2 in areas of cerebral hypoxia after CA. Our results also indicate that epinephrine could compromise cerebral microcirculatory flow after CA, similar to its effects in a piglet model of CA where despite increase in cerebral perfusion pressure after epinephrine infusion, microcirculatory blood flow decreased (30) . As epinephrine is frequently used clinically postresuscitation from CA to stabilize hemodynamic parameters, it would be important to determine if other strategies to raise MAP might be able to improve PbO 2 and microcirculatory flow. While MAP was measured during the epinephrine infusion, measurement of the intracranial pressure to assess the cerebral perfusion pressure could have given us additional information regarding the cerebrovascular effect of epinephrine.
We chose to study the effect on PbO 2 of two clinically relevant and frequently used therapies during post-CA syndrome: oxygen and epinephrine. Other clinical strategies to augment PbO 2 , such as blood transfusion, administration of pentobarbital or controlled hypoventilation, not studied here, might have some utility.
We found some degree of variability of PbO 2 in our study, both in shams and injured rats. This variability was observed in other studies (15) and is consistent with data showing that cortical PbO 2 varies with as much as 20 mm Hg depending on the cortical area and layers of the somatosensory cortex (31) . Likewise, hippocampal PbO 2 varies within different areas (32) . Our data suggest, however, that marked reductions of PbO 2 in the cortex are observed after CA and represent a potential therapeutic target for postresuscitation approaches designed to raise PbO 2.
The ratio of PbO 2 /PaO 2 followed the same pattern as PbO 2 (data not shown), confirming that the region-specific variability to PbO 2 in response to CA is not a function of changes in FiO 2 . We found some variability in our physiological data. The thalamic group with lower MAP (12 min asphyxial CA) had a similar PbO 2 tracing with the 9 min thalamic group, and thus MAP values were unlikely to have affected our results. We . Black circles represent cortical PbO 2 , white circles represent thalamic PbO 2 , black diamonds represent mean arterial pressure (MAP) for the cortical group, and white diamonds represent MAP for the thalamic group. n = 6 per group. *P < 0.05 vs. before epinephrine. 
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Articles also observed a decrease in hemoglobin of 0.9-1.5 mg/dl over time in all groups due to blood sampling, with no difference between groups. In our model, we observe a similar decrease in hemoglobin in sham rats with no change in PbO 2 , suggesting that this degree of decrease in hemoglobin does not affect PbO 2 in sham or injured rats. Relevant to the current study, in previous studies, we did not observe sex-based differences in postarrest CBF (3), although we observed a sex-based difference in response to a specific treatment (polynitroxyl albumin) (33) . As one aspect of the current study was to evaluate PbO 2 as a potential surrogate for continuous CBF measurements after CA, we chose to limit the experiments to males. Future studies using PbO 2 , particularly those evaluating treatments, should include males and females.
In this model of pediatric asphyxial CA, selective neuronal death in cortex, thalamus, hippocampus, and cerebellum is seen, along with behavioral deficits (34, 35) . However, the relationship between cortical PbO 2 and histopathological and functional outcome in our model remains to be determined. The threshold for cortical hypoxia that produces neuronal injury may even be lower than 10 mm Hg and remains uncertain. Age-related differences in the PbO 2 threshold for hypoxia after CA also remain undefined. An intriguing hypothesis is that postischemic thalamic hyperoxia might also be detrimental. Further experiments in our model assessing the PbO 2 threshold and whether goal-directed PbO 2 therapy improves outcome are warranted.
In conclusion, PbO 2 after asphyxial CA in immature rats is region dependent: there is cortical hypoxia but early thalamic hyperoxia. These findings mimic the pattern of CBF in this model, suggesting that PbO 2 is representative of oxygen delivery and CBF. Increasing supplemental oxygen improves cortical hypoxia. If our model translates to the human condition, these data suggest a possible utility for PbO 2 monitoring after CA in children. Further studies in this model are warranted to assess if goal directed therapy targeting cerebral oxygenation improves outcome after experimental pediatric asphyxial CA.
METHODS
Studies were approved by the Institutional Animal Care and Use Committee at the University of Pittsburgh, and the care and handling of the animals were in accord with the National Institutes of Health (Bethesda, MD) guidelines. We used male postnatal day 16-18 Sprague-Dawley rats (30-46 g; n = 56). We measured PbO 2 after CA in the cortex and thalamus in separate groups of rats after asphyxial CA and the response of PbO 2 to hyperoxia or MAP augmentation after CA.
Anesthesia and Surgery
Rats were initially anesthetized with 3% isoflurane/50% N 2 O/balance O 2 in a Plexiglas chamber (Henry Schein, US) until unconscious and then their tracheas were intubated with an 18-gauge angio catheter (Becton, Dickinson and Company, US). Mechanical ventilation was started and ventilatory rates and tidal volumes were adjusted to maintain PaCO 2 at 35-45 mm Hg. Femoral arterial and venous catheters (PE 10) were inserted to monitor MAP and infuse medications. During surgery, anesthesia was maintained with 1.5% isoflurane/50% N 2 O/balance O 2 . Isoflurane was discontinued after the placement of arterial and venous catheters, and anesthesia was maintained with fentanyl as described below. MAP and heart rate were continuously monitored. Rectal temperature was maintained at 37 °C using a heated water blanket.
PbO 2 Electrode Placement
The head was stabilized in a stereotaxic instrument using ear bars. A small burr hole (2 mm) was drilled in the skull 2 mm lateral and 3.3 mm posterior to bregma. PbO 2 was measured continuously using a Clark type tissue electrode (Ox-50, Unisense, Denmark) inserted at either a depth of 1 mm for cortical PbO 2 measurements or at a depth of 6 mm for thalamic PbO 2 measurements. We chose to measure PbO 2 in the cortex and thalamus because these are brain regions with the lowest or highest postresuscitation CBF, respectively, in our previous report (3) . The location of the electrode in the cortex or thalamus was verified in brain sections after injection of Evans Blue (Sigma Aldrich, US) at the conclusion of the experiment. Brain temperature was continuously monitored with an intraparenchymal sensor. Three groups (cortical 9 and 12 min groups and thalamic 9 min groups) had mean brain temperatures between 36.2 °C and 36.9 °C. Due to an experimental oversight, the thalamic 12-min group did not have brain temperature monitored; however, the body temperature, which parallels the brain temperature in our model, was maintained constant in this group. Baseline parameters for MAP, PaO 2 , pH, PaCO 2 , and PbO 2 were obtained immediately before the asphyxial insult.
PbO 2 Measurements in Shams Under Different Anesthetic Conditions
In pilot experiments, we determined the effects of two anesthetics: isoflurane and fentanyl on cortical and thalamic PbO 2 in sham rats. Cortical PbO 2 was measured in one group and thalamic PbO 2 in the other (n = 8, 4 per group). Each group initially was anesthetized with isoflurane, and PbO 2 was measured after a 10-min stabilization period. Isoflurane was then discontinued, and a fentanyl infusion at 50 µg kg −1 h −1 was started. The rats were observed for 30 min prior to measuring the PbO 2 to assure wash out of isoflurane. Cortical PbO 2 values were similar using isoflurane or fentanyl anesthesia. Thalamic PbO 2 were higher using isoflurane vs. fentanyl anesthesia (109 ± 32% increase in thalamic PbO 2 using isoflurane vs. fentanyl; P < 0.05). Therefore, in all CA experiments, anesthesia was maintained with fentanyl infusion to minimize effects of anesthesia on PbO 2 .
Asphyxial CA
We used an established asphyxial CA protocol (3). Rats received intravenous fentanyl infusion at 50 µg kg −1 h −1 to provide anesthesia and vecuronium infusion at 5 mg kg −1 h −1 to induce neuromuscular blockade. We used fentanyl as the anesthetic agent during the CA experiments because it is clinically relevant, and unlike the inhaled anesthetics, it does not affect CBF (19) . The FiO 2 was reduced from 0.5 to 0.21 for 1 min before asphyxia to avoid preinsult hyperoxygenation. The tracheal tube was disconnected from the ventilator for 9 or 12 min. Resuscitation was started by reconnecting the ventilator and reinstituting mechanical ventilation at an FiO 2 of 1.0. Epinephrine (0.005 mg kg −1 ) and sodium bicarbonate (1 mEq kg −1 ) were administered intravenously, followed by manual chest compressions until return of spontaneous circulation. The fentanyl infusion was restarted 30 min after resuscitation at the prearrest infusion rate. At 30 min after resuscitation, FiO 2 was decreased to 0.5. This oxygenation sequence during cardiopulmonary resuscitation and postresuscitation is consistent with common clinical practice at our institution. Arterial blood gas measurements were obtained at the time of arterial catheter insertion, at 30 and 60 min after CA and at the end of the experiment, and the ventilatory rates and tidal volumes were adjusted to a target of PaCO 2 of 35-45 mm Hg. SatO 2 was measured continuously with a pulse oximeter (MouseOx, Starr Life Sciences).
PbO 2 Measurements During and After CA
In separate groups of rats, cortical or thalamic PbO 2 were measured continuously before, during, and after 9 or 12 min asphyxial CA (n = 6 per group for thalamic PbO 2 measurements and n = 12 per group for cortical PbO 2 measurements). PbO 2 was recorded for analysis at baseline and at the following time points postresuscitation: 5, 10, 15, 30, 60, and 120 min. At the completion of 120-min postresuscitation period, these rats underwent PbO 2 measurements to assess the response to supplemental oxygen or epinephrine as described below.
